Figure 3
From: Plasticity and intratumoural heterogeneity of cell surface antigen expression in breast cancer
CD9 expression associates with epithelial phenotype, cancer progression and recurrence-free survival in a cohort of breast cancer patients. (A) Correlation analysis shows relationship between CD9 and EPCAM mRNA expression in clinical samples. (B) A plot shows expression of CD9 and EpCAM mRNA in non-metastatic primary tumours (met negative n=55) and primary tumours that disseminated to distant sites (met positive n=27; GSE2603). (C) The graph shows recurrence-free survival analysis in cohort of breast cancer patients according to high or low CD9 expression levels (GSE2603).
